Qifeng Xie
- Topics
- COVID-19 Clinical Research Studies (5 papers)Hepatitis B Virus Studies (4 papers)Sepsis Diagnosis and Treatment (3 papers)
In The Last Decade
Qifeng Xie
12 papers receiving 206 citations
Peers
Comparison fields: 5 of 55
- Infectious Diseases 139
- Neurology 73
- Epidemiology 31
- Electrical and Electronic Engineering 25
- Oncology 23
Countries citing papers authored by Qifeng Xie
This map shows the geographic impact of Qifeng Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Xie more than expected).
Fields of papers citing papers by Qifeng Xie
This network shows the impact of papers produced by Qifeng Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Xie. The network helps show where Qifeng Xie may publish in the future.
Co-authorship network of co-authors of Qifeng Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng Xie. A scholar is included among the top collaborators of Qifeng Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng Xie. Qifeng Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 18 | |
| 3 | 14 | |
| 4 | 18 | |
| 5 | 97 | |
| 6 | 8 | |
| 7 | 27 | |
| 8 | 1 | |
| 9 | [The relationship between the levels of HBV DNA loads and both the clinical characteristics and 48-week prognosis in patients with decompensated cirrhosis due to hepatitis B]. | 1 |
| 10 | [The antiviral treatment impacts on clinical outcomes of renal transplantation recipients with hepatitis B virus infection]. | 1 |
| 11 | [Hepatitis B virus X protein suppressing adriamycin-induced apoptosis of HepG2 cells]. | 1 |
| 12 | 10 |
About Qifeng Xie
Qifeng Xie is a scholar working on Infectious Diseases, Hepatology and Epidemiology, having authored 12 papers that have together received 209 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Hepatitis B Virus Studies (4 papers) and Sepsis Diagnosis and Treatment (3 papers). The work is most often cited by research in Infectious Diseases (139 citations), Neurology (73 citations) and Bioengineering (11 citations). Qifeng Xie has collaborated with scholars based in China, India and Pakistan. Frequent co-authors include Zheying Liu, Conglin Wang, Zhifeng Liu, Li Zhong, Ming Wu, Jingjing Ji, Lei Su, Ziyun Shao, Yongwen Feng and Zhengtao Gu. Their work appears in journals such as IEEE Sensors Journal, International Immunopharmacology and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.